104 related articles for article (PubMed ID: 1362242)
1. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin.
Ahmad S; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Glazer RI
Mol Pharmacol; 1992 Dec; 42(6):1004-9. PubMed ID: 1362242
[TBL] [Abstract][Full Text] [Related]
2. Expression of the antisense cDNA for protein kinase C alpha attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells.
Ahmad S; Glazer RI
Mol Pharmacol; 1993 Jun; 43(6):858-62. PubMed ID: 8100351
[TBL] [Abstract][Full Text] [Related]
3. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells.
Aftab DT; Yang JM; Hait WN
Oncol Res; 1994; 6(2):59-70. PubMed ID: 7949466
[TBL] [Abstract][Full Text] [Related]
4. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
Scala S; Dickstein B; Regis J; Szallasi Z; Blumberg PM; Bates SE
Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959
[TBL] [Abstract][Full Text] [Related]
5. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
[TBL] [Abstract][Full Text] [Related]
6. Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein.
Yu G; Ahmad S; Aquino A; Fairchild CR; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Cowan KH; Glazer RI
Cancer Commun; 1991 Jun; 3(6):181-9. PubMed ID: 1675575
[TBL] [Abstract][Full Text] [Related]
7. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.
Chaudhary PM; Roninson IB
Oncol Res; 1992; 4(7):281-90. PubMed ID: 1360276
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate.
Schwartz GK; Arkin H; Holland JF; Ohnuma T
Cancer Res; 1991 Jan; 51(1):55-61. PubMed ID: 1824824
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein, multidrug resistance and protein kinase C.
Fine RL; Chambers TC; Sachs CW
Stem Cells; 1996 Jan; 14(1):47-55. PubMed ID: 8820951
[TBL] [Abstract][Full Text] [Related]
10. Correlation of multidrug resistance with up-regulation of protein kinase C expression in KBV200 cells.
Yuan YW; Sun AM; Li CG
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1341-3, 1356. PubMed ID: 16305951
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
[TBL] [Abstract][Full Text] [Related]
12. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.
Drew L; Groome N; Warr JR; Rumsby MG
Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200
[TBL] [Abstract][Full Text] [Related]
13. Changes in protein kinase C subspecies protein expression and activity in a series of multidrug-resistant human KB carcinoma cell lines.
Drew L; Groome N; Hallam TJ; Warr JR; Rumsby MG
Oncol Res; 1994; 6(9):429-38. PubMed ID: 7703529
[TBL] [Abstract][Full Text] [Related]
14. Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin.
Evans CH; Baker PD
Cancer Res; 1992 Nov; 52(21):5893-9. PubMed ID: 1356622
[TBL] [Abstract][Full Text] [Related]
15. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.
Ford JM; Bruggemann EP; Pastan I; Gottesman MM; Hait WN
Cancer Res; 1990 Mar; 50(6):1748-56. PubMed ID: 1968358
[TBL] [Abstract][Full Text] [Related]
16. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells.
Posada J; Vichi P; Tritton TR
Cancer Res; 1989 Dec; 49(23):6634-9. PubMed ID: 2819714
[TBL] [Abstract][Full Text] [Related]
18. Expression of protein kinase C in human renal cell carcinoma cells with inherent resistance to doxorubicin.
Efferth T; Volm M
Anticancer Res; 1992; 12(6B):2209-11. PubMed ID: 1363517
[TBL] [Abstract][Full Text] [Related]
19. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
[TBL] [Abstract][Full Text] [Related]
20. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells.
Dong ZY; Ward NE; Fan D; Gupta KP; O'Brian CA
Mol Pharmacol; 1991 Apr; 39(4):563-9. PubMed ID: 2017156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
